Azilsartan medoxomil potassium
Product Description
Zhejiang Tianyu Pharmaceutical Co. Ltd
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
Categories
Specifications
Zhejiang Tianyu Pharmaceutical Co. Ltd
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:3
-
Employees:1000 - 4999
Company types
Primary activities
More Products from Zhejiang Tianyu Pharmaceutical Co. Ltd (99)
-
Product Brivaracetam
DMF is available -
Product Apalutamide
DMF is available. -
Product Apixaban
DMF is available. -
Product Aprocitentan
DMF is available. -
Product Avatrombopag maleate
DMF is available -
Product Azilsartan
DMF is available. -
Product Antihypertensive/Antihypercholesterolemic,Antigout/Antilipemic
Azilsartan Azilsartan medoxomil potassium Candesartan cilexetil Irbesartan Losartan potassium Olmesartan medoxomil Sacubitril Valsartan Sodium Telmisartan Valsartan Nebivolol hydrochloride Aprocitentan** -
Product Anti angina pectoris/Analgesic /Antimigraine
Nicorandil Mirogabalin besylate Rimegepant sulfate Ubrogepant -
Product Anticancer
Cabozantinib malate Enzalutamide Ibrutinib Abemaciclib Elacestrant dihydrochloride** Ribociclib succinate** Acalabrutinib* Alectinib hydrochloride* Darolutamide* Pirtobrutinib Apalutamide -
Product Anticoagulant/Antiplatelet/Antithrombocytopenics
Apixaban Dabigatran etexilate mesylate Edoxaban tosylate monohydrate Rivaroxaban Ticagrelor Avatrombopag maleate -
Product Antidiabetic/Diabetic nephropathy
Canagliflozin hemihydrate Dapagliflozin Dapagliflozin free base Empagliflozin Sitagliptin hydrochloride monohydrate Sitagliptin phosphate monohydrate Vildagliptin Bexagliflozin Teneligliptin hydrobromide hydrate Finerenone -
Product (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile (Intermediate of Vildagliptin)
Zhejiang Tianyu Pharmaceutical Co. Ltd offers a wide range of product which includes (s)-1-(2-chloroacetyl)pyrrolidine-2-carbonitrile (intermediate of vildagliptin). It belongs to pharmaceutical intermediates category. Contact us for more information.
